INmune Bio gets MHRA alignment for 2026 UK drug application

Go back to INmune Bio gets MHRA alignment for 2026 UK drug application
(NASDAQ: INMB) Delayed: 2.33 +0.15 (6.88%)
Previous Close $2.18    52 Week High
Open $2.22    52 Week Low
Day High $2.40    P/E N/A 
Day Low $2.21    EPS
Volume 677,642